Wednesday, December 7, 2016

BRIEF-Kitov completes KIT-302 testing required for NDA to U.S. FDA

* Kitov Pharmaceuticals Holdings - Kitov expects to submit

additional stability data to FDA at a later time, in order to

extend labeled shelf life

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)